Loading clinical trials...
Loading clinical trials...
Comparative Effectiveness of Three Devices for Transcatheter Closure of Atrial Septal Defects for Adults: A Pilot Study (Trio-ASD)
Conditions
Interventions
AMPLATZER™ Septal Occluder.
Occlutech Figulla Flex II®
+1 more
Locations
4
Canada
St. Paul's Hospital
Vancouver, British Columbia, Canada
Toronto General Hospital
Toronto, Ontario, Canada
Institut de Cardiologie de Montreal (MHI)
Montreal, Quebec, Canada
Institut Universitaire de Cardiologie Et Pneumologie de Quebec/Hopital Laval
Québec, Quebec, Canada
Start Date
November 23, 2022
Primary Completion Date
October 1, 2024
Completion Date
October 1, 2024
Last Updated
April 6, 2023
NCT06590467
NCT06347276
NCT06849635
NCT05887700
NCT06298344
NCT06431178
Lead Sponsor
University Health Network, Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions